Orion Portfolio Solutions’s Immunocore IMCR Stock Holding History

Orion Portfolio Solutions’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$680K	Buy	22,934 +9,917	+76%	+$297K	0.01%	1260
2024 Q4	$384K	Sell	13,017 -7,675	-37%	-$243K	﹤0.01%	1443
2024 Q3	$644K	Sell	20,692 -2,282	-10%	-$83K	0.01%	1238
2024 Q2	$779K	Sell	22,974 -153	-0.7%	-$7.8K	0.01%	1092
2024 Q1	$1.5M	Buy	23,127 +5,826	+34%	+$400K	0.02%	793
2023 Q4	$1.2M	Sell	17,301 -3,248	-16%	-$169K	0.01%	869
2023 Q3	$1.07M	Buy	20,549 +4,645	+29%	+$275K	0.01%	905
2023 Q2	$954K	Buy	+15,904	New	+$908K	0.01%	974

Other funds holding IMCR

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Orion Portfolio Solutions's IMCR Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Immunocore (IMCR) stake by 76% in Q1 2025, buying an estimated $297K and bringing the position to 22,934 shares worth $680K. The position accounts for 0.01% of the portfolio, ranked #1260.

Orion Portfolio Solutions first reported a position in IMCR in Q2 2023 and has held it in 8 quarters since. The position peaked at $1.5M in Q1 2024. 116 funds tracked by Wall St. Rank hold IMCR as of Q1 2025.

Orion Portfolio Solutions held 22,934 shares of Immunocore worth $680K as of Q1 2025.
Orion Portfolio Solutions bought 9,917 Immunocore shares in Q1 2025, an estimated $297K.
Immunocore made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1260 holding.
Orion Portfolio Solutions first reported a position in Immunocore in Q2 2023 and has held it in 8 quarters since.
Orion Portfolio Solutions's Immunocore position peaked at $1.5M in Q1 2024.
116 funds tracked by Wall St. Rank held Immunocore as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.